IRVINE, CA / ACCESSWIRE / June 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Asanko Gold Inc. (“Asanko” or the “Company”) (NYSE MKT: AKG). Investors who purchased or otherwise acquired shares between October 24, 2014 and May 31, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the July 31, 2017 lead plaintiff motion deadline.

If you purchased Asanko shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Asanko made false and/or misleading statements and/or failed to disclose that: the Company’s Mineral Resource Estimates are flawed; that some of Asanko’s resources models exhibit signs that they have been “smeared,” which would cause estimates of their ore contents to be inflated; and that as a result of the above, Asanko’s public statements were materially false and misleading at all relevant times. When this news reached the public, Asanko’s share price dropped materially, which caused investors harm.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for nearly two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 467180

IRVINE, CA / ACCESSWIRE / June 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Intra-Cellular Therapies, Inc. (“Intra-Cellular” or the “Company”) (NASDAQ: ITCI). Investors, who purchased or otherwise acquired shares from August 12, 2014 through April 28, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the July 11, 2017 lead plaintiff motion deadline.

If you purchased Intra-Cellular shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Intra-Cellular made false and/or misleading statements and/or failed to disclose: that findings related to toxicity in animals treated with lumateperone (ITI-007) were observed; that these findings posed an additional safety concern about lumateperone; and that, as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. On August 4, 2016, the Company’s Chief Executive Officer, Sharon Mates, touted the “efficacy and safety of ITI-007 for the treatment of schizophrenia.” On May 1, 2017, Intra-Cellular disclosed that the FDA requested information from the Company in order to verify whether or not there are safety risks associated with long term exposure of ITI-007 to patients. Upon release of this information, Intra-Cellular’s stock price fell materially, which harmed investors according to the Complaint.

If you want to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 467178

IRVINE, CA / ACCESSWIRE / June 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Barrick Gold Corporation (“Barrick” or the “Company”) (NYSE: ABX). Investors who purchased or otherwise acquired Barrick shares from February 16, 2017 through April 24, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the July 10, 2017 lead plaintiff motion deadline.

If you purchased shares of Barrick during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.

According to the Complaint, during the Class Period, Barrick made materially false and/or misleading statements, and failed to disclose: that the pipes and safety systems at the Veladero mine were not strong enough to prevent gold-bearing solution spills; that Argentinian authorities would restrict the addition of cyanide to the Veladero mine’s heap leach facility and require remedial work; that these developments would impact the production capacity of the Veladero mine; that Barrick’s Veladero mine production guidance and total gold production guidance were overstated; and that as a result of the above, the Company’s statements about its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times. On April 24, 2017, Barrick revised its full year guidance, stating that “[f]ull-year gold production is now expected to be 5.3-5.6 million ounces, down from our previous range of 5.6-5.9 million ounces.” Barrick attributed about two-thirds of the decrease to the planned sale of 50% percent of its Veladero mine. The Company also changed its Veladero-specific guidance, forecasting full-year production of 630,000-730,000 ounces at Veladero, compared to its previously-issued guidance of 770,000-830,000 ounces. Upon release of this information to the public, Barrick’s stock price fell materially, which harmed investors according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esquire, a prominent litigator for almost two decades, by telephone at (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 467176

IRVINE, CA / ACCESSWIRE / June 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Akari Therapeutics, Plc (“Akari” or the “Company”) (NASDAQ: AKTX). Investors, who purchased or otherwise acquired Akari shares from March 30, 2017 through May 11, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the July 11, 2017 lead plaintiff motion deadline.

If you purchased Akari shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Akari made materially false and/or misleading statements, and/or failed to disclose that: its Chief Executive Officer, Dr. Gur Roshwalb, and possibly other executives, were involved in publishing false information about the Company, including false information about the Phase 2 PNH trial of Coversin; that Akari lacked sufficient checks and protections to prevent such behavior; and that, as a result of the above, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis. On May 11, 2017, Akari announced that Dr. Roshwalb has been placed on administrative leave while the Board of Directors reviews whether Dr. Roshwalb and other executives were involved in a materially inaccurate research report that was released and subsequently withdrawn in April 26, 2017 by Edison Investment Research Ltd. When this information was released, Akari’s stock price fell materially, which harmed investors according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 467177

IRVINE, CA / ACCESSWIRE / June 29, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a securities class action lawsuit against Mazor Robotics Ltd. (“Mazor Robotics” or the “Company”) (NASDAQ: MZOR). Investors who purchased or otherwise acquired shares between November 8, 2016 and June 8, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the August 8, 2017 lead plaintiff motion deadline.

If you purchased Mazor Robotics shares during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.

The Complaint alleges that throughout the Class Period, Mazor Robotics made false and misleading statements and/or failed to disclose: that the Company was engaged in conduct that subjected it to an Israeli Securities Authority (“ISA”) investigation and exposed it to potential liability; and that as a result, the Company’s statements about its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. On June 8, 2017, Mazor Robotics disclosed that in May 2017, the ISA searched its offices and questioned certain of its officers regarding an investigation. When this news was announced, the Company’s stock price fell materially, which harmed investors according to the Complaint.

If you wish to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, Esquire, a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 467174

IRVINE, CA / ACCESSWIRE / June 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Signet Jewelers Limited (“Signet” or the “Company”) (NYSE: SIG). Investors who purchased or otherwise acquired shares from August 29, 2013 through February 27, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the updated July 5, 2017 lead plaintiff motion deadline.

If you purchased shares of Signet during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

The Complaint alleges that during the Class Period, Signet issued false and misleading statements and/or failed to disclose that alleged sexual harassment by employees of Signet’s Sterling Family of Jewelers division (“Sterling”) – including numerous incidents of sexual assault and rape which were detailed in approximately 249 declarations signed under penalty of perjury by current and former Sterling employees – made it unlikely that Signet would be able to avoid paying a sizable amount of damages in connection with a class action lawsuit filed by Sterling employees. Signet’s shares traded at artificially inflated prices during the Class Period as a result of this information being withheld from the market. On February 27, 2017, The Washington Post reported on widespread allegations of sexual harassment made in the private arbitration that implicated the Company’s senior managers and executives. Following this news, Signet’s stock price dropped materially, which caused investors harm.

If you wish to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 467175

IRVINE, CA / ACCESSWIRE / June 29, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a securities class action lawsuit against CenturyLink, Inc. (“CenturyLink” or the “Company”) (NYSE: CTL). Investors who purchased or otherwise acquired shares between February 27, 2014 and June 15, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the August 21, 2017 lead plaintiff motion deadline.

If you purchased CenturyLink shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.

According to the Complaint, during the Class Period, CenturyLink made false and/or misleading statements and/or failed to disclose: that the Company’s policies allowed its employees to add services or lines to accounts without customer permission, resulting in millions of dollars in unauthorized charges; that revenues were the product of illicit conduct and unsustainable; that this illicit conduct was likely to subject CenturyLink to heightened regulatory scrutiny; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. On June 16, 2017, Bloomberg reported on a lawsuit filed by a former CenturyLink employee who alleges that she was fired for blowing the whistle on the high-pressure sales culture that caused customers to pay millions of dollars for accounts they did not request, to Chief Executive Officer Glen Post. When this news reached the public, shares of CenturyLink declined in value, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 467172

IRVINE, CA / ACCESSWIRE / June 29, 2017 / Khang & Khang LLP (the “Firm”) announces the filing of a securities class action lawsuit against Booz Allen Hamilton Holding Corporation (“Booz Allen” or the “Company”) (NYSE: BAH). Investors, who purchased or otherwise acquired shares between May 19, 2016 and June 15, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the August 18, 2017 lead plaintiff motion deadline.

If you purchased shares of Booz Allen during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.

According to the Complaint, throughout the Class Period, Booz Allen made false and misleading statements and/or failed to disclose that: the Company engaged in improper accounting practices in its contracts with the U.S. government; that its revenues derived from services provided to the U.S. government were inflated and unsustainable; that the discovery of such conduct would subject the Company to heightened regulatory scrutiny, potential criminal sanctions, and jeopardize its business relationship with the U.S. government; and that as a result of the above, Booz Allen’s public statements were materially false and misleading at all relevant times.

On June 15, 2017, the Company disclosed that on June 7, 2017, the Company’s wholly-owned subsidiary Booz Allen Hamilton Inc. “was informed that the U.S. Department of Justice is conducting a civil and criminal investigation relating to certain elements of the Company’s cost accounting and indirect cost charging practices with the U.S. government.” When this news was announced, shares of Booz Allen dropped in value materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 467173